Cargando…
The impact of the correction of hyponatremia during hospital admission on the prognosis of SARS-CoV-2 infection()
BACKGROUND: SARS-CoV-2 infection is frequently associated with hyponatremia (plasma sodium <135 mmol/L), being associated with a worse prognosis. The incidence of hyponatremia is estimated to be 20–37% according to the series, but there are no data on the prognosis after correction of hyponatremi...
Autores principales: | de La Flor, José C., Gomez-Berrocal, Ana, Marschall, Alexander, Valga, Francisco, Linares, Tania, Albarracin, Cristina, Ruiz, Elisa, Gallegos, Gioconda, Gómez, Alberto, de los Santos, Andrea, Rodeles, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240945/ https://www.ncbi.nlm.nih.gov/pubmed/35784827 http://dx.doi.org/10.1016/j.medcle.2021.07.021 |
Ejemplares similares
-
Impacto de la corrección temprana de la hiponatremia en el pronóstico de la infección del síndrome respiratorio agudo grave del coronavirus 2 (SARS-CoV-2)
por: de La Flor, José C., et al.
Publicado: (2022) -
Targeting Cytokine Storm in COVID-19: A Role of Online Hemodiafiltration with Asymmetric Cellulose Triacetate in Maintenance Hemodialysis Patients—A Report of 10 Cases
por: De La Flor, José C., et al.
Publicado: (2021) -
Patiromer in a Patient with Severe Hyperkalemia on Incremental Hemodialysis with 1 Session per Week: A Case Report and Literature Review
por: De La Flor, José C., et al.
Publicado: (2021) -
Un caso de nefritis tubulointersticial aguda después de la vacunación con Pfizer-BioNTech COVID-19
por: de la Flor Merino, José Carlos, et al.
Publicado: (2022) -
A case of acute interstitial nephritis following the Pfizer–BioNTech COVID-19 vaccine
por: de la Flor Merino, José Carlos, et al.
Publicado: (2022)